{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:06:29Z","timestamp":1783595189126,"version":"3.55.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1097\/tp.0000000000002033","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T20:05:29Z","timestamp":1511381129000},"page":"664-672","source":"Crossref","is-referenced-by-count":50,"title":["Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients"],"prefix":"10.1097","volume":"102","author":[{"given":"Patrick B.","family":"Trotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic M.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Ushiro-Lumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andrew","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.E.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R5-29-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajt.12094","article-title":"Screening of donor and recipient in solid organ transplantation","volume":"13","author":"Fischer","year":"2013","journal-title":"Am J Transplant"},{"key":"R6-29-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.12095","article-title":"Donor-derived infections in solid organ transplantation","volume":"13","author":"Ison","year":"2013","journal-title":"Am J Transplant"},{"key":"R7-29-20210129","first-page":"140","article-title":"Management of hepatitis C post-liver transplantation: a comprehensive review","volume":"3","author":"Mitchell","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"R8-29-20210129","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"Kwo","year":"2014","journal-title":"N Engl J Med"},{"key":"R9-29-20210129","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(14)61795-5","article-title":"Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial","volume":"385","author":"Lawitz","year":"2015","journal-title":"Lancet"},{"key":"R10-29-20210129","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/TP.0000000000001336","article-title":"Successful posttransplant treatment of hepatitis C with ledipasvir-sofosbuvir in HIV+ kidney transplant recipients","volume":"101","author":"Sawinski","year":"2017","journal-title":"Transplantation"},{"key":"R11-29-20210129","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1097\/TP.0000000000001618","article-title":"Safety and efficacy of treatment of hepatitis c in kidney transplant recipients with directly acting antiviral agents","volume":"101","author":"Lubetzky","year":"2017","journal-title":"Transplantation"},{"key":"R12-29-20210129","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1097\/TP.0000000000001758","article-title":"Elbasvir\/grazoprevir use in postliver transplantation patients on hemodialysis","volume":"101","author":"Martin","year":"2017","journal-title":"Transplantation"},{"key":"R13-29-20210129","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"key":"R14-29-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ki.2015.180","article-title":"Hepatitis C virus infection and kidney transplantation: newer options and a brighter future ahead?","volume":"88","author":"Del Bello","year":"2015","journal-title":"Kidney Int"},{"key":"R15-29-20210129","doi-asserted-by":"crossref","first-page":"e0158431","DOI":"10.1371\/journal.pone.0158431","article-title":"Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"key":"R16-29-20210129","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/TP.0000000000001414","article-title":"Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipients","volume":"101","author":"Eisenberger","year":"2017","journal-title":"Transplantation"},{"key":"R17-29-20210129","first-page":"454","article-title":"Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation","volume":"29","author":"Hori","year":"2016","journal-title":"Ann Gastroenterol"},{"key":"R18-29-20210129","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.27681","article-title":"Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation","volume":"61","author":"Forns","year":"2015","journal-title":"Hepatology"},{"key":"R19-29-20210129","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"R22-29-20210129","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/TP.0b013e31823f14d4","article-title":"A simplified Donor Risk Index for predicting outcome after deceased donor kidney transplantation","volume":"93","author":"Watson","year":"2012","journal-title":"Transplantation"},{"key":"R23-29-20210129","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/TP.0000000000001576","article-title":"Factors associated with short- and long-term liver graft survival in the United Kingdom: development of a UK Donor Liver Index","volume":"101","author":"Collett","year":"2017","journal-title":"Transplantation"},{"key":"R28-29-20210129","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ajt.13620","article-title":"Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents","volume":"16","author":"Sawinski","year":"2016","journal-title":"Am J Transplant"},{"key":"R29-29-20210129","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/TP.0000000000001410","article-title":"Use of HCV+ donors does not affect HCV clearance with directly acting antiviral therapy but shortens the wait time to kidney transplantation","volume":"101","author":"Sawinski","year":"2016","journal-title":"Transplantation"},{"key":"R30-29-20210129","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/TP.0000000000001467","article-title":"Sofosbuvir\/ledipasvir without ribavirin achieved high sustained virologic response for hepatitis C recurrence after liver transplantation: two-center experience","volume":"101","author":"Elfeki","year":"2017","journal-title":"Transplantation"},{"key":"R31-29-20210129","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ajg.2014.66","article-title":"The rapid evolution of treatment strategies for hepatitis C","volume":"109","author":"Muir","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R32-29-20210129","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(13)62121-2","article-title":"Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial","volume":"383","author":"Lawitz","year":"2014","journal-title":"Lancet"},{"key":"R33-29-20210129","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med"},{"key":"R34-29-20210129","first-page":"23","article-title":"Treatment of Hepatitis C Virus infection in liver transplant recipients","volume":"12","author":"Suraweera","year":"2016","journal-title":"Gastroenterol Hepatol (N Y"},{"key":"R36-29-20210129","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1600-6143.2009.02782.x","article-title":"Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ use","volume":"9","author":"Reese","year":"2009","journal-title":"Am J Transplant"},{"key":"R37-29-20210129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-6143.2009.02931.x","article-title":"Centers for disease control \u201chigh-risk\u201d donors and kidney utilization","volume":"10","author":"Duan","year":"2010","journal-title":"Am J Transplant"},{"key":"R38-29-20210129","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/ajt.13283","article-title":"Transmission of hepatitis C virus from organ donors despite nucleic acid test screening","volume":"15","author":"Suryaprasad","year":"2015","journal-title":"Am J Transplant"},{"key":"R39-29-20210129","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/TP.0000000000001727","article-title":"Deceased organ donors with a history of increased risk behavior for the transmission of blood-borne viral infection: the UK experience","volume":"101","author":"Trotter","year":"2017","journal-title":"Transplantation"},{"key":"R40-29-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"R41-29-20210129","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/ajt.12703","article-title":"Epstein-Barr virus infection in adult renal transplant recipients","volume":"14","author":"Morton","year":"2014","journal-title":"Am J Transplant"},{"key":"R42-29-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C-positive kidneys","volume":"373","author":"Reese","year":"2015","journal-title":"N Engl J Med"},{"key":"R43-29-20210129","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2215\/CJN.03680316","article-title":"New opportunities for funding dialysis-dependent undocumented individuals","volume":"12","author":"Raghavan","year":"2017","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:30:56Z","timestamp":1620977456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201804000-00029"}},"subtitle":["A Potential Cost-Effective Approach to Save Lives?"],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002033","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}